WA
Waystar
WAY · NASDAQ
$25.66 -4.61% (-$1.24)
1M +2.60%
Market Cap $5.08B
P/E Ratio 37.71x
Div. Yield -
ROE 3.59%
Piotroski F-Score Moderate
5/9Valuation
49 /100
Fair P/E 37.71x
EV/EBITDA 15.15x
P/FCF 20.64x
Growth
96 /100
Growing Rev. growth 15.97%
FCF growth 49.24%
Book val. growth 22.57%
Profitability
92 /100
Strong Gross margin 69.11%
Net margin 11.18%
FCF margin 20.42%
Quality
17 /100
Poor ROIC 3.37%
ROE 3.59%
Asset turnover 0.21x
Debt
63 /100
Moderate Debt/Equity 0.37x
Current ratio 1.85x
Net debt/EBITDA 3.40x
Stability
33 /100
Unstable Beta 0.07x
Rev. volatility 3.56%
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o WAY
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Matthew J. Hawkins
Employees
1,700
Headquarters
Lehi
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report